Category Archives: Unenforceability

Gilead Sciences, Inc. v. Merck & Co., et al.

Docket No. 2016-2302, -2615 TARANTO, CLEVENGER, CHEN April 25, 2018 Brief summary: DC’s “unenforceability judgment based on unclean hands” with respect to Merck’s patents relating to Gilead’s Sovaldi® and Harvoni® Hepatitis C treatements affirmed. Summary: Merck appealed the DC’s “unenforceability … Continue reading

Posted in Attorney's Fees, Unenforceability | Leave a comment